Search for 'Provider:Journal of Crohn's and Colitis,'

Surgical repair and biological therapy for fecal incontinence in Crohn's disease involving both sphincter defects and complex fistulas

By Grau Sanz, Montserrat. Journal of Crohn's and Colitis, 2011 . 5(6):598-607. , Formato Vancouver: Aldea M, Clofent J, Núñez de Arenas C, Chamorro M, Velasco M, Berrendero JR, et al. Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer. Cancer Lett. 2011;311(2):210-8.

Place Hold on Surgical repair and biological therapy for fecal incontinence in Crohn's disease involving both sphincter defects and complex fistulas

Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.

By Sicilia, Beatriz | Casís Herce, Begoña | Martínez Montiel, Pilar. Journal of Crohn's & colitis, 2014 . 8(3):240-51. , Formato Vancouver: Calvet X, Panés J, Alfaro N, Hinojosa J, Sicilia B, Gallego M et al. Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. J Crohns Colitis. 2014 Mar;8(3):240-51.

Place Hold on Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.

The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry.

By Medina Benítez, Enrique. Journal of Crohn's & colitis, 2014 . 8(8):763-9. , Formato Vancouver: Martín de Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez Gómez MJ, Medina E et al; SPIRIT-IBD Working Group of SEGHNP (Sociedad Española de Gastroenterología Hepatología Nutrición Pediátrica). The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry. J Crohns Colitis. 2014 Aug;8(8):763-9.

Place Hold on The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry.

Incidence, management, and course of cancer in patients with inflammatory bowel disease.

By Casís Herce, Begoña. Journal of Crohn's & colitis, 2015 . 9(4):326-33. , Formato Vancouver: Algaba A, Guerra I, Marín Jiménez I, Quintanilla E, López Serrano P, García Sánchez MC et al. Incidence, management, and course of cancer in patients with inflammatory bowel disease. J Crohns Colitis. 2015 Apr;9(4):326-33.

Place Hold on Incidence, management, and course of cancer in patients with inflammatory bowel disease.

Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient.

By Martínez Montiel, Pilar | Piedracoba Cadahia, Carlos | Gómez Gómez, Carlos | Gonzalo, J. Journal of Crohn's & colitis, 2015 . 9(9):816-7. , Formato Vancouver: Martínez Montiel M, Piedracoba Cadahia P, Gómez Gómez C, Gonzalo J. Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient. J Crohns Colitis. 2015 Sep;9(9):816-7.

Place Hold on Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient.